Value Added Technology (043150) Q1 2025 earnings summary

Executive summary

• Achieved consolidated revenue of KRW 101.3 billion in Q1 2025, up 7.5% year-over-year, driven by expanded U.S. dealer network, increased 3D product sales, and strong export-driven performance in over 90 countries.

• Operating profit rose 28.4% sequentially to KRW 13.2 billion, but declined 8.2% year-over-year due to higher costs and SG&A expenses.

• Net income attributable to owners decreased 32.3% year-over-year to KRW 11.7 billion, impacted by lower equity method income.

• The group operates a global dental imaging business with 23 subsidiaries, a leading position in dental CT, and a robust IP portfolio of 425 patents.

• Emphasizes premium product strategy, customer-centric service, and continuous innovation for both mature and emerging markets.

Financial highlights

• Gross profit margin was 53.0%, down from 53.5% a year ago but up sequentially.

• Operating profit margin improved to 13.0% from 10.1% in the previous quarter, but down from 15.3% a year ago.

• Net profit margin declined to 11.5% from 18.3% in 1Q24.

• 3D (CBCT) product sales grew 0.9% year-over-year and 9.4% sequentially, while IOX and related products surged 50.2% year-over-year.

• Cash and cash equivalents at quarter-end were KRW 93.7 billion, up from KRW 89.6 billion at the end of 2024.

Outlook and guidance

• Plans to expand 3D premium and entry product sales in response to market shift from 2D to 3D.

• Focus on strengthening product quality, technology, and customer service to enhance market dominance.

• Targeting developed markets with large FOV models and emerging markets with entry-level models.

• Strengthening premium product lineup, expanding digital platforms, and enhancing global brand recognition.

• Continued investment in R&D and digital transformation to support sustainable growth.